Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects
NCT01527656
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Healthy
Interventions
DRUG:
biphasic insulin aspart 70
Sponsor
Novo Nordisk A/S